Muscle Loss on GLP-1 Medication: What’s Happening and How to Fight It

Quick Answer

Muscle loss on GLP-1 medication is common: in body-scan substudies of two large trials, 25% to 38% of the weight lost was lean mass, about half of it muscle.

  • Eat 1.2 to 1.5 g protein per kg of body weight daily while losing weight.
  • Strength train two to three times a week or more; one advisory says at least three.
A coiled resistance band beside a protein-rich meal, representing the two levers against muscle loss on GLP-1 medication.

Most of the conversation around GLP-1 medications focuses on appetite suppression, nausea, and how fast the weight comes off. Muscle loss on GLP-1 medication rarely gets the same airtime. For many people it goes unnoticed until they’re several months into treatment and start wondering why they feel weaker than expected. This isn’t a reason to avoid the medication. It’s a reason to go in knowing what to watch for.

Why Does GLP-1 Medication Cause Muscle Loss?

Weight loss, by itself, always involves some muscle loss. The body doesn’t selectively burn fat when it’s in a calorie deficit. It draws on available energy from both fat stores and lean tissue, and the balance between the two depends on how much protein you’re eating and whether you’re giving your muscles a reason to stay.

GLP-1 medications speed that process up by reducing appetite. People eat less overall, which is the point, but when total food intake drops without deliberate attention to protein, the diet that remains often skews toward easy foods rather than protein-dense ones. What changes most is the total. More weight off means more lean tissue off in absolute terms even when the split stays close to where dieting alone would put it.

How much muscle goes also depends on how hard calories are cut, how fast the weight comes off, and whether you do strength training, according to a 2025 joint advisory from four US lifestyle medicine, nutrition and obesity societies. The same advisory says low protein intake from a smaller appetite may add to muscle loss.

How Much of the Weight Lost on GLP-1 Medication Is Muscle?

In body-scan substudies of two large trials, between a quarter and over a third of the weight lost was lean mass, and about half of lean mass is muscle.

A DXA substudy of the SURMOUNT-1 tirzepatide trial, published in Diabetes, Obesity and Metabolism, measured body composition in 160 participants at baseline and again at week 72. Of the weight lost, about 74 percent was fat and 26 percent was lean mass on tirzepatide, against 75 and 25 percent on placebo. That split is close to what dietary weight loss produces on its own, and the same paper says so. What changes the stakes here is how much comes off, and whether protein intake and resistance training are holding the lean side up.

The size of the loss does not move that split much. Grouping the same participants by how much total weight they lost, the substudy reports 70, 73 and 76 percent of it coming from fat as the totals rise, and its authors conclude that tirzepatide does not drive disproportionate lean mass loss even at the larger reductions. What a bigger loss does change is the absolute kilograms of lean tissue leaving, which is why the preservation work gets more urgent rather than less.

Semaglutide’s figure is higher. In the STEP 1 trial, 5.3 kg of the average 13.6 kg lost was lean mass, or 38%, according to the joint advisory. Lean mass is everything that is not fat, so it counts muscle along with other tissue. Muscle makes up about half of it, which puts muscle at roughly a fifth of the weight lost.

Sex matters too. Modelling cited in the same advisory puts muscle at 10% to 15% of the weight lost in women and 20% to 25% in men, for people who are not doing structured strength training.

Some of this is expected. The 2025 expert panel in Obesity Pillars calls some loss of muscle “inevitable and natural” with substantial weight loss, and says it does not necessarily weaken people. On these drugs specifically, it finds that current evidence does not consistently show excess loss of muscle or strength.

What Does Muscle Loss Cost You?

Muscle isn’t just about appearance. It’s metabolically active tissue. More muscle means a higher resting metabolic rate, which is how many calories your body burns at rest. Lose muscle during a weight loss phase and you’re left with a lower maintenance calorie threshold than you started with. Keeping the weight off from there takes more restriction than it did before.

There’s also the functional side. Muscle supports joint stability, balance, and the ability to stay active as you age. Sarcopenia, the age-related loss of muscle mass and strength, is a real and serious condition. Losing muscle during a weight loss phase on top of natural age-related loss compounds a problem that becomes progressively harder to reverse.

With muscle loss on GLP-1 medication, the quality of what remains matters as well as the amount. Fat also builds up inside muscle, and rising levels of it have been linked with worsening muscle function. In an MRI study added to the SURPASS-3 trial and published in The Lancet Diabetes & Endocrinology, people with type 2 diabetes took tirzepatide for 52 weeks and had their thighs scanned at the start and the end. On average, their thigh muscle shrank by about 0.64 litres, close to what population data predict for that much weight loss. The fat inside it fell further than predicted.

Read that as an early signal with limits. The analysis was run after the trial, which was not designed to study muscle, and it did not account for diet or exercise, so its authors call the result hypothesis-generating. Eli Lilly, which makes tirzepatide, funded it and took part in the analysis and writing. At the highest dose, muscle size adjusted for body size also fell more than the population data predict.

The frustrating part is that rebuilding muscle is harder and slower than losing it. Protecting what you have during treatment is significantly more efficient than trying to recover it afterward.

What Limits Muscle Loss on GLP-1 Medication?

Protein and resistance training are what both expert groups recommend, and they work as a pair. The joint advisory says more protein alone is likely not enough to keep muscle without strength training, and the expert panel says a high protein intake alone does not increase muscle mass. Neither is complicated, but both take deliberate effort when appetite is suppressed.

Protein Intake

The standard recommendation of 0.8 grams of protein per kilogram of body weight per day was developed for generally healthy, sedentary adults. It wasn’t designed for people in a medically supported calorie deficit losing weight at pace.

The figure I use is 1.2 to 1.5 grams of protein per kilogram of actual body weight per day, which is what the 2025 modified-Delphi consensus in Obesity Pillars recommends for the rapid weight loss phase. Once weight is being maintained, the same panel drops to 0.8 grams per kilogram or above.

The guidance is not settled. The joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and the Obesity Society, in the American Journal of Lifestyle Medicine, reports proposals as high as 1.2 to 1.6 grams per kilogram during active weight reduction, and sets no single body-weight figure of its own. It calls 1.5 grams per kilogram of fat-free mass the more accurate measure, then says plainly that it is unclear whether the goal should be based on actual weight, corrected weight or fat-free mass, because actual weight can overstate the requirement.

On the panel’s range, the daily figure climbs quickly with body weight. Multiply your weight in kilograms by 1.2 and by 1.5 for the weight-loss phase, and by 0.8 for the floor once weight is steady.

Body weight Protein a day while losing weight (1.2 to 1.5 g per kg) Protein a day once weight is steady (at least 0.8 g per kg)
70 kg (154 lb) 84 to 105 g 56 g or more
90 kg (198 lb) 108 to 135 g 72 g or more
110 kg (243 lb) 132 to 165 g 88 g or more
130 kg (287 lb) 156 to 195 g 104 g or more

The advisory’s caveat applies to every row. For people with obesity, it says, using actual weight can significantly overestimate protein needs. If your figure looks out of reach, set it with your prescriber or a dietitian.

The free Protein Calculator can help you work out a personalised target based on your weight and activity level.

The challenge is hitting those numbers on a reduced appetite. The practical approach is to lead every meal with protein rather than treating it as an afterthought. Eggs, Greek yoghurt, cottage cheese, chicken, fish, and legumes all deliver meaningful protein in smaller volumes. When whole food alone isn’t enough, a whey protein powder with 25 to 30 grams per serve is a reasonable tool for filling the gap.

For that gap, the comparison of protein shakes and powders for GLP-1 users picks a powder that puts 25 g of protein into 5 to 6 fl oz of liquid, a drink small enough to finish, with a dairy-free option and a ready-made bottle for days when mixing one is too much.

Resistance Training

Protein tells the body what to preserve. Resistance training tells it why. Without a mechanical stimulus on the muscle, there’s no signal to maintain it. Cardio has its place, but it doesn’t provide that signal the way resistance work does.

You don’t need a complicated programme, and the two expert groups differ only a little on how often. The expert panel notes that guidelines from AACE, EASO and the American College of Sports Medicine recommend resistance training two to three times a week. The joint advisory suggests at least three times a week, plus at least 150 minutes of moderate aerobic exercise, and says structured strength or mixed training is well established to help preserve lean mass while weight comes off.

Compound movements such as squats, hinges, rows and presses cover most of the body. The GLP-1 Workout Guide has a structured programme built specifically for people on medication, including guidance on managing sessions when energy is lower than usual.

Resistance bands are worth considering if gym access is limited or if fatigue makes heavier training difficult to sustain. A set covers most compound movement patterns at home and scales easily as strength improves.

Intensity matters as well: the expert panel advises resistance training at moderate to high intensity to preserve lean mass.

Creatine comes up often as an add-on to training. A 2017 meta-analysis, a study that pools the results of earlier trials, combined 22 trials in older adults. Published in the Open Access Journal of Sports Medicine, it found that people taking creatine during resistance training gained about 1.4 kg more lean tissue than those training with a placebo. A 2023 meta-analysis in Nutrients, which measured muscle directly with scans, found a very small effect, smaller still in older adults. Its authors say part of the lean gains seen in earlier studies may be fluid.

Neither looked at people on GLP-1 medication. Doses in the trials that the 2017 meta-analysis pooled ran 3 to 5 g a day, some after a short loading phase. The creatine section of the supplement comparison shows which tub carries that dose with nothing else in it.

Drugs meant to protect muscle during GLP-1 weight loss have only phase 2 results so far, and none is approved for that use. In one phase 2 trial in Nature Medicine, funded by its maker Scholar Rock, people on tirzepatide plus apitegromab lost 1.9 kg less lean mass over 24 weeks than those on tirzepatide plus placebo, with similar weight loss. The guide to myostatin inhibitors for GLP-1 muscle loss tracks where each one stands.

Are Older Adults at Higher Risk of Muscle Loss on GLP-1 Medication?

People over 60 should pay particular attention to this issue. Anabolic resistance, the reduced ability of older muscle tissue to respond to protein intake, means the body needs more protein per kilogram to achieve the same muscle protein synthesis response as a younger adult. The margin for error is smaller.

Age is one of several flags. The expert panel lists older age, more severe obesity, diabetes and being post-menopausal as groups that may be particularly susceptible, and aims its protein advice particularly at older adults and anyone at risk of sarcopenia. The joint advisory adds lower testosterone, a mostly sedentary day and no strength training.

This doesn’t mean GLP-1 medication is inappropriate for older adults. It means that protein targets and resistance training become even more important, not optional. If you’re in this age group and haven’t discussed muscle preservation strategies with your healthcare provider, that’s worth raising at your next appointment.

How Do You Know If You’re Losing Muscle on GLP-1 Medication?

The problem with muscle loss is that it’s not always visible in the early stages. The scale goes down, which reads as success. But total weight lost doesn’t tell you the composition of that loss.

Body weight alone isn’t enough. Tracking how you feel physically, whether strength is holding steady in training, and whether you’re consistently hitting protein targets gives you a clearer picture.

Measurement helps where you can get it. The joint advisory calls bioelectrical impedance, a quick electrical body-composition reading taken at the clinic, the practical option for repeat checks. A DXA scan is the gold standard but costs more, and the advisory suggests one every year or two, which may be too far apart to catch early loss.

These scans measure how much muscle you have, not how well it works. For strength, the advisory notes that grip strength is slow to show change, while sit-to-stand, stair-climb and timed up-and-go tests can help in older adults. Ask your prescriber which of these they offer.

What Should You Do Next?

Muscle loss on GLP-1 medication is real and common. Expert guidance points to two inputs that limit it: enough protein and regular resistance training. The medication does the work on appetite and weight loss. The gap it creates around food volume is the thing to manage deliberately.

Eat protein first. Train with resistance two to three times a week or more. Track your intake. Those three things will do more for your body composition outcomes than most other changes you could make during treatment.

Plan past the last dose too. When GLP-1s are stopped, up to two-thirds of the lost weight is commonly regained within a year, the joint advisory notes, even alongside standard nutrition counselling or behavioural therapy. The protein and strength habits built during treatment are the ones to keep.

The free GLP-1 tools include the protein calculator above and a macro tracker for logging what you eat.

Get the 8-Week GLP-1 Strength Plan

Eight weeks of sessions planned out, three a week across ten movements, so each time you train you know what to do and when to step it up. Mobility work, a plan for the bad days, and a tracker with a row for every week. Free, sent to your inbox.

GLP Playbook - Strength Plan Magnet Capture

This also adds you to my monthly roundup: what is new on the site, plus any discount codes I have that month. The codes only go out in that email.

Your plan lands first, then a few helpful emails on strength training while on GLP-1 medication. Unsubscribe anytime.

References

  1. Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes, Obesity and Metabolism. 2025;27(5):2720-2729. Funded by Eli Lilly. pmc.ncbi.nlm.nih.gov/articles/PMC11965027
  2. Mozaffarian D, et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Lifestyle Medicine. 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12125019
  3. Sievenpiper JL, et al. Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies: an expert consensus statement using a modified Delphi approach. Obesity Pillars. 2025;17:100228. Nestlé Health Science funded project management and medical writing; the panel states the content was developed independently. All 15 authors report honoraria from Nestlé Health Science for the panel meetings. pmc.ncbi.nlm.nih.gov/articles/PMC12768930
  4. Sattar N, Neeland IJ, Dahlqvist Leinhard O, et al. Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial. The Lancet Diabetes & Endocrinology. 2025;13(6):482-493. Funded by Eli Lilly, which took part in the design, analysis and writing. thelancet.com
  5. Chilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access Journal of Sports Medicine. 2017;8:213-226. pmc.ncbi.nlm.nih.gov/articles/PMC5679696
  6. Burke R, et al. The Effects of Creatine Supplementation Combined with Resistance Training on Regional Measures of Muscle Hypertrophy: A Systematic Review with Meta-Analysis. Nutrients. 2023;15(9):2116. Three authors report links to creatine makers or creatine-industry research, and two of them have current ties. pmc.ncbi.nlm.nih.gov/articles/PMC10180745
  7. Pratley RE, et al. Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial (EMBRAZE). Nature Medicine. 2026. Funded by Scholar Rock, which makes apitegromab. nature.com